The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: Conceptual framework and therapeutic potential
| Title: | The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: Conceptual framework and therapeutic potential |
|---|---|
| Authors: | Fruchart J. -C.; Santos R. D.; Aguilar-Salinas C.; Aikawa M.; Al Rasadi K.; Amarenco P.; Barter P. J.; Ceska R.; Corsini A.; Despres J. -P.; Duriez P.; Eckel R. H.; Ezhov M. V.; Farnier M.; Ginsberg H. N.; Hermans M. P.; Ishibashi S.; Karpe F.; Kodama T.; Koenig W.; Krempf M.; Lim S.; Lorenzatti A. J.; McPherson R.; Nunez-Cortes J. M.; Nordestgaard Bo. G.; Ogawa H.; Packard C. J.; Plutzky J.; Ponte-Negretti C. I.; Pradhan A.; Ray K. K.; Reiner Z.; Ridker P. M.; Ruscica M.; Sadikot S.; Shimano H.; Sritara P.; Stock J. K.; Su T. -C.; Susekov A. V.; Tartar A.; Taskinen M. -R.; Tenenbaum A.; Tokgozoglu L. S.; Tomlinson B.; Tybjaerg-Hansen A.; Valensi P.; Vrablik M.; Wahli W.; Watts G. F.; Yamashita S.; Yokote K.; Zambon A.; Libby P. |
| Contributors: | Fruchart, J. -C.; Santos, R. D.; Aguilar-Salinas, C.; Aikawa, M.; Al Rasadi, K.; Amarenco, P.; Barter, P. J.; Ceska, R.; Corsini, A.; Despres, J. -P.; Duriez, P.; Eckel, R. H.; Ezhov, M. V.; Farnier, M.; Ginsberg, H. N.; Hermans, M. P.; Ishibashi, S.; Karpe, F.; Kodama, T.; Koenig, W.; Krempf, M.; Lim, S.; Lorenzatti, A. J.; Mcpherson, R.; Nunez-Cortes, J. M.; Nordestgaard, Bo. G.; Ogawa, H.; Packard, C. J.; Plutzky, J.; Ponte-Negretti, C. I.; Pradhan, A.; Ray, K. K.; Reiner, Z.; Ridker, P. M.; Ruscica, M.; Sadikot, S.; Shimano, H.; Sritara, P.; Stock, J. K.; Su, T. -C.; Susekov, A. V.; Tartar, A.; Taskinen, M. -R.; Tenenbaum, A.; Tokgozoglu, L. S.; Tomlinson, B.; Tybjaerg-Hansen, A.; Valensi, P.; Vrablik, M.; Wahli, W.; Watts, G. F.; Yamashita, S.; Yokote, K.; Zambon, A.; Libby, P. |
| Publisher Information: | BioMed Central Ltd. |
| Publication Year: | 2019 |
| Collection: | Padua Research Archive (IRIS - Università degli Studi di Padova) |
| Subject Terms: | Atherogenic dyslipidemia; Diabete; Inflammation; Pemafibrate (K-877); PROMINENT; Remnant cholesterol; Residual cardiovascular risk; Selective peroxisome proliferator-activated receptor alpha modulator; SPPARMalpha; Triglyceride; Visceral obesity |
| Document Type: | article in journal/newspaper |
| Language: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/31164165; info:eu-repo/semantics/altIdentifier/wos/WOS:000470305900001; volume:18; issue:1; firstpage:71; lastpage:90; numberofpages:20; journal:CARDIOVASCULAR DIABETOLOGY; https://hdl.handle.net/11577/3303387; http://www.cardiab.com/home/ |
| DOI: | 10.1186/s12933-019-0864-7 |
| Availability: | https://hdl.handle.net/11577/3303387; https://doi.org/10.1186/s12933-019-0864-7; http://www.cardiab.com/home/ |
| Rights: | info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by/4.0/ |
| Accession Number: | edsbas.C3C9C50D |
| Database: | BASE |